Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist first synthesised in 2000 as an active metabolite and structural refinement of Melanotan II itself a synthetic analogue of alpha-melanocyte-stimulating hormone (-MSH) originally developed as a sunless tanning agent
Dont navigate these challenges alone
Reduced Risk of Cardiovascular Disease: Studies have shown that semaglutide not only helps manage diabetes but also reduces the risk of major adverse cardiovascular events such as cardiovascular death, non-fatal myocardial infarction, or nonfatal stroke in patients with established cardiovascular disease [8]
In most instances of pathogenic variants in the G6PD gene the resulting disease it is due to protein instability as a result of the amino acid substitution
US$ 26.81
US$ 25.68
US$ 26.87
US$ 20.91
US$ 29.59
US$ 26.74
US$ 20.42
US$ 25.88
